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Abstract
Hexagonal-shaped human corneal endothelial cells (HCEC) form a monolayer by adhering tightly through their intercellular
adhesion molecules. Located at the posterior corneal surface, they maintain corneal translucency by dehydrating the
corneal stroma, mainly through the Na
+- and K
+-dependent ATPase (Na
+/K
+-ATPase). Because HCEC proliferative activity is
low in vivo, once HCEC are damaged and their numbers decrease, the cornea begins to show opacity due to overhydration,
resulting in loss of vision. HCEC cell cycle arrest occurs at the G1 phase and is partly regulated by cyclin-dependent kinase
inhibitors (CKIs) in the Rb pathway (p16-CDK4/CyclinD1-pRb). In this study, we tried to activate proliferation of HCEC by
inhibiting CKIs. Retroviral transduction was used to generate two new HCEC lines: transduced human corneal endothelial
cell by human papillomavirus type E6/E7 (THCEC (E6/E7)) and transduced human corneal endothelial cell by Cdk4R24C/
CyclinD1 (THCEH (Cyclin)). Reverse transcriptase polymerase chain reaction analysis of gene expression revealed little
difference between THCEC (E6/E7), THCEH (Cyclin) and non-transduced HCEC, but cell cycle-related genes were up-
regulated in THCEC (E6/E7) and THCEH (Cyclin). THCEH (Cyclin) expressed intercellular molecules including ZO-1 and N-
cadherin and showed similar Na
+/K
+-ATPase pump function to HCEC, which was not demonstrated in THCEC (E6/E7). This
study shows that HCEC cell cycle activation can be achieved by inhibiting CKIs even while maintaining critical pump
function and morphology.
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Introduction
Human corneal endothelial cells (HCEC) are hexagonal in shape
and form a fragile monolayer lying posterior to the surface of the
cornea. These cells maintain corneal transparency by their tight
intercellular barrier and perform an ion transport pump function
through Na
+/K
+-ATPase, which regulates the hydration of the
corneal stroma [1,2]. If HCEC sustain damage, excessive hydration
and opacity of the cornea occur, resulting in decreased vision.
Corneal endothelia are believed not to increase in adult humans
and in fact gradually decrease by approximately 0.5% per year
[3,4,5]. Damage, injury or HCEC disease such as Fuchs’ corneal
dystrophy [6], diabetes [7], trauma [8], cataract surgery [9] or
elevation of intraocular pressure [10] does not lead to increased
proliferation but rather to an increase in cell size to compensate for
the wounded area [11]. Once the cell number falls below 1,000
cells/mm
2, the monolayer of enlarged HCEC cannot maintain
corneal translucency [12] and surgical treatment is required to
restore vision.
Penetrating keratoplasty has long been the surgical treatment of
choice, involving replacement of a total layer of cornea by donor
material. However, it can also result in adverse effects such as
astigmatism and severe rejection requiring long term usage of
immunosuppressive drugs [13]. Recently, alternative transplanta-
tion strategies, including modified posterior lamellar keratoplasty
techniques such as deep lamellar endothelial keratoplasty (DLEK)
[14], Descemet’s stripping with endothelial keratoplasty (DSEK)
[15] and Descemet membrane endothelial keratoplasty (DMEK)
[16] have been introduced to overcome these problems. Despite
these advances, an increasingly aging population requiring corneal
transplants and inadequate tissue quality limit the availability of
donor corneas, such that alternative ways of preparing endothelial
cell monolayers need to be explored.
HCEC were originally believed to be incapable of expanding
in vitro, but have been successfully isolated and cultured by
introducing stimulating agents such as epidermal growth factor,
platelet-derived growth factor-BB, bovine pituitary extract and
fetal bovine serum [17,18]. However, the number of cells with
proliferative activity and the ability to respond to such agents is
relatively low, and much variation in proliferative activity exists
between donors of different ages [19,20]. Thus, there is a
requirement to achieve a stable and effective culture of cells in
terms of both cell proliferation and physiologic function.
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pathways, both of which have been inactivated by human
papilloma virus (HPV) type 16 E6/E7 to successfully immortalize
cells. Kim et al. reported the establishment of an immortalized
HCEC line using HPV type 16 E6/E7 on lyophilized human
amniotic membrane [21]. However, several studies have reported
carcinogenesis of the cell line established by viral oncogenes
including HPV type 16 E6/E7 or SV40 large T antigen [22,23].
Therefore a corneal endothelial cell line developed in this way
does not appear to be suitable for the treatment of human corneal
diseases. To resolve this problem, we expressed mutant cyclin-
dependent kinase (Cdk) 4 and CyclinD1 to inactivate the pRB
pathway and generate corneal endothelial cell lines without
transducing viral oncogenes.
Results
HCEC with Descemet’s membranes were proliferated slowly in
a culture dish coated in type IV collagen. After two passages, the
cells were transferred into 24-well dishes and transfected with a
retroviral vector carrying E6/E7 or mutant Cdk4 and CyclinD1.
Three cell lines were successfully generated, as shown in Fig. 1A,
with obvious differences in growth (Fig. 1B). Protein expression
from the transduced gene was confirmed by western blotting
(Fig. 1C). As previously reported [21], THCEC (E6/E7) was
immortalized, and THCEC (Cyclin) demonstrated the same
proliferative capacity as THCEC (E6/E7), while primary cells
grew more slowly even when cultured in 10% fetal bovine serum.
These results indicate that induction of mutant Cdk4 and
CyclinD1 is sufficient to generate a HCEC line that proliferates
at a faster rate than the primary cell line.
Proliferation capacity was also confirmed by immunohisto-
chemistry of Ki-67 (Fig. 2A). Expression of downstream genes of
CyclinD1 which are associated with cell proliferation was analyzed
by real-time polymerase chain reaction (PCR) (Fig. 2B). Positive
staining of Ki-67, which is detected in the nucleus, was confirmed
in both THCEC (Cyclin) and THCEC (E6/E7). Real-time PCR
also revealed that CDC2 and PCNA, target genes of E2F (an
upstream transcriptional factor), that are activated by CyclinD1,
were up-regulated in THCEC (E6/E7) and especially in THCEC
(Cyclin).
Expression of genes involved in active transmembrane trans-
porter activity, including Na
+/K
+-ATPase, or cell adhesion,
including ZO-1 and N-cadherin, were assessed by semi-quantita-
tive reverse transcriptase (RT)-PCR (Fig. 3A). Expression of
intercellular adhesion molecules was confirmed by immunohisto-
chemistry (Fig. 3B–J). Semi-quantitative RT-PCR showed that
there was no significant difference between the three cell lines
regarding the expression of genes associated with several molecules
of cell adhesion or of ion transporter channels, which are
characteristically expressed by HCEC [21,24]. This was also
confirmed by real-time PCR (data not shown).
ZO-1 and N-cadherin, key HCEC adhesion molecules [24],
demonstrated positive staining at the intercellular junction in
HCEH (Fig. 3F, I) and THCEC (Cyclin) (Fig. 3E, H), while
neither ZO-1 nor N-cadherin was detected in THCEC (E6/E7)
despite sufficient cellular density (Fig. 3G, J). Although positive
staining of ZO-1 and N-cadherin was observed at the intercellular
junction in THCEC (Cyclin), ZO-1 staining also occurred around
the nucleus (Fig. 3E), indicating the immature distribution of the
ZO-1 protein. In THCEC (Cyclin) and HCEC, hexagonal
morphology was identified both by phase-contrast micrography
(Fig. 3B, C) and immunocytochemistry, while the structure of
hexagonal cell shape was not maintained in THCEC (E6/E7)
(Fig. 3D). These data indicate that THCEC (Cyclin) and HCEC,
but not THCEC (E6/E7), maintain contact inhibition which is
crucial for preserving the monolayer.
Scanning electron microscopy was performed to reveal detailed
information on the cellular junction (Fig. 4). THCEC (Cyclin) and
HCEC showed a clear cellular junction including a tight junction,
whereas THCEC (E6/E7) grew as a multilayer without forming a
cellular junction, which confirms the immunohistochemistry
result.
Representative traces of circuit current driven by the Na
+/K
+-
ATPase were of similar shapes in both HCEC and THCEC
(Cyclin) (Fig. 5A). These circuit currents maintain corneal
translucency and their levels in both cell lines were clearly reduced
by the presence of the Na
+/K
+-ATPase inhibitor ouabain, which
confirms that the origin of the current is Na
+/K
+-ATPase.
Meanwhile, the pump function in THCEC (Cyclin), detected in
both earlier and later passages of cells, was more variable than that
in HCEC (Fig. 5B), possibly indicating incomplete Na
+/K
+-
ATPase activity or the presence of an intercellular barrier that
regulates ion permeability. No regular circuit current was detected
in THCEC (E6/E7) (Fig. 5A, B), which probably reflects the
absence of intercellular adhesion preventing free ion transport
across the membrane. This experiment clearly showed that the
THCEC (Cyclin) monolayer has similar Na
+/K
+-ATPase activity
to that of HCEC.
A tumorigenesis assay of nude mice detected no solid tumor in
either THCEC (Cyclin) or THCEC (E6/E7), while HeLa cells
formed a solid tumor in all mice (Table 1). Since THCEC (Cyclin)
has a similar morphology and pump function to HCEC, THCEC
(Cyclin) could be suitable for HCEC studies.
Discussion
THCEC (E6/E7) was shown to achieve immortalization with a
highly activated proliferative capacity, as previously described
[21]. However, the cell lines did not show normal intercellular
contact or normal pump function, probably because contact
inhibition in the cell line was not achieved. Meanwhile, THCEC
(Cyclin) was demonstrated to have normal physiologic function
with a greater proliferative capacity than primary cells, but slightly
lower than that of THCEC (E6/E7).
In expanding the cellular life span, E7 has been shown to play a
role in the inactivation of pRB, while E6 activates telomerase [25]
and accelerates p53 degradation, which induces the Cdk inhibitor
p21 [26]. However, little is known about the effector sites of the
viral oncogene that may be related to genetic instability of
immortalized cells. In the present study, expression of genes
specific to HCEC was not drastically different between the three
cell lines. However, key proteins including ZO-1 and N-cadherin
that are important in forming intercellular contacts were detected,
probably because of the unknown influence of viral oncogenes on
post-translational modification, posttranslational import or protein
stability/degradation.
We recently established genetically stable, non-transformed
immortalized ovarian surface epithelium (OSE) cell lines without
viral oncogenes by expressing mutant Cdk 4, CyclinD1 and
hTERT, based on the hypothesis that inactivation of the pRb
pathway and activation of telomerase are sufficient for OSE
immortalization [27]. Meanwhile, Rane et al. demonstrated that
mutant Cdk 4 (Cdk4R24C) is sufficient to induce carcinogenesis in
several other tissues including those of the pancreas, pituitary and
brain [28], and Joyce and colleagues showed that HCEC are
arrested in the G1 phase and regulated by CKIs, p16INK4a and
p21WAF1/Cip1 [29]. Considering the importance of maintaining
Corneal Endothelial Cell Line with Pump Function
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transduced mutant Cdk 4 and CyclinD1, not hTERT, in the
present study. We believe that our careful method enabled
THCEC (Cyclin) to form a fragile and regularly arranged
monolayer complete with physiologic function.
Although THCEC (Cyclin) has similar characteristics to
primary HCEC, immunohistochemistry and the Ussing chamber
assay also highlighted the differences between the cells. ZO-1
protein was expressed around the nucleus of THCEC (Cyclin) but
not in primary cells. Since semi-quantitative PCR detected almost
the same level of mRNA expression between the cell lines, staining
around the nucleus in THCEC (Cyclin) probably reflects an error
in posttranslational import of ZO-1 protein. The Ussing chamber
assay detected a similar pump function between THCEC (Cyclin)
and primary cells, but the current in THCEC (Cyclin) was more
variable than that of the primary cells, which might have been
caused by reduced Na
+/K
+-ATPase activity, immature intercel-
lular adhesion allowing irregular intercellular ion transport or
differences in cellular density.
Cells established by a retrovirus carry a potential risk of
promoting carcinogenesis [30], and direct transplantation to
humans of cell sheets composed of such cells may lead to complex
problems. Recently, to resolve this problem, several studies have
reported the establishment of untransfected corneal endothelial
cell lines [31,32,33], which are the most ideal cell lines for the
treatment of human corneal disease. Meanwhile, alternative
bioengineering approaches, including lipofection of p27kip1
siRNA [34], proteomics technology analyzing the difference
between younger and older HCEC [35] and drug usage of
promyelocytic leukemia zinc finger protein, a cell cycle transcrip-
tional repressor and negative regulator [36], have also been
introduced. The present findings support the idea that targeting
the interaction between p16INK4a and Cdk4 using such methods
is a promising strategy to generate HCEC with sufficient
proliferative capacity and physiologic function.
Materials and Methods
Isolation and cell culture of human corneal cells
Ethics Statement. A cornea was excised from the surgically
enucleated eye of a 2-year-old infant undergoing therapy for
retinoblastoma, with the approval (approval number, #156) of the
Figure 1. Establishment of THCEC (E6/E7), THCEC (Cyclin) and HCEC. (A) HCEC with Descemet’s membrane were placed on Type IV collagen-
coated 35 mm cell culture dishes with growth medium (P0). After one passage (P1), retroviral infection was conducted in 6-well cell culture dishes at
P2. THCEC (E6/E7) and THCEC (Cyclin) were infected by retroviral vectors carrying HPV16 E6/E7 and both CyclinD1 and Cdk4R24C, respectively. (B)
Growth curves of THCEC (E6/E7), THCEC (Cyclin) and HCEC cell lines. THCEC (E6/E7) was immortalized as reported previously, and THCEC (Cyclin)
obtained the same proliferative activity as that of THCEC (E6/E7). Transfection was performed on day 0 for THCEC (E6/E7) and THCEC (Cyclin), with
population doublings of 2. For HCEC, primary culture commenced on day 0. (C) Western blotting confirmed the expression of the following
transgenes: E6 and E7 in THCEC (E6/E7), and CyclinD1 and Cdk4R24C in THCEC (Cyclin).
doi:10.1371/journal.pone.0029677.g001
Corneal Endothelial Cell Line with Pump Function
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Health Development, Tokyo, Japan. Signed informed consent
was obtained from the donor’s parents, and the surgical specimens
were irreversibly de-identified. All experiments handling human
cells and tissues were performed in line with the tenets of the
Declaration of Helsinki.
The corneal piece, which was grossly normal with no
pathological lesions, was cut 1.5 mm from the corneal limbus,
Figure 2. Evaluation of proliferative capacity. (A) Immunohistochemistry of Ki-67 in three cell lines. Positive staining of Ki-67, located in the
nucleus, was obviously identified in THCEC (Cyclin) and THCEC (E6/E7), but rarely detected in HCEC. (B) Real-time PCR of downstream genes of
cyclinD1 associated with proliferation. Gene expression levels of both CDC2 and PCAN were clearly higher than that of HCEC. The gene expression
was much more activated in THCEC (Cyclin) in which the expression of E2F, an upstream transcriptional factor of two genes, was constitutively
activated by transduced mutant Cdk4 and CyclinD1.
doi:10.1371/journal.pone.0029677.g002
Figure 3. HCEC-associated genes and cytolocalization of junctional components expressed by cell lines. (A) Semi-quantitative reverse
transcriptase polymerase chain reaction for HCEC-associated genes. Total RNA was prepared from cultured cells seven days after reaching confluency.
No significant difference in mRNA expression was observed between the three cell lines. Compared with phase-contrast micrographs of (B) THCEC
(Cyclin), (C) HCEC and (D) THCEC (E6/E7), cytolocalization was examined by immunofluorescence staining of ZO-1 (E, F,G) and N-cadherin (H, I, J).
THCEC (E6/E7) did not stain positive for intercellular junctional molecules, while ZO-1 and N-cadherin stained positive at the junction in THCEC
(Cyclin) and HCEC.
doi:10.1371/journal.pone.0029677.g003
Corneal Endothelial Cell Line with Pump Function
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with Descemet’s membrane were stripped from the posterior
surface of the corneal tissue with sterile surgical forceps under a
dissecting microscope. They were cut into two pieces and cultured
in a cell culture dish covered with Type IV collagen in a growth
medium (GM); Dulbecco’s modified Eagle’s medium (DMEM)/
Nutrient mixture F12 (1:1) with high glucose supplemented
with 10% fetal bovine serum, insulin-transferrin-selenium and
MEM-NEAA (Gibco, Auckland, NZ). Cells were subcultured after
reaching confluency by treating with trypsin/EDTA and seeded at
a density of 5610
5 cells/well in 6-well dishes.
Viral vector construction and viral transduction
Lentiviral vector plasmids, CSII-CMV-cyclin D1 and -
CDK4R24C were constructed by recombination using the
Gateway system (Invitrogen, Carlsbad, CA) as described previ-
ously [37]. Briefly, cDNAs of human cyclinD1 and a mutant
form of Cdk4 (Cdk4R24C: an inhibitor resistant form of Cdk4,
generously provided by Dr Hara) were recombined with a
lentiviral vector, CSII-CMV-RfA (a gift from Dr Miyoshi), by
LR reaction to create a Gateway expression plasmid (Invitrogen)
according to the manufacturer’s instructions.
Previous work has described the production of recombinant
lentiviruses with the vesicular stomatitis virus G glycoprotein
[37], the recombinant retrovirus vector plasmid, pCLXSN-
16E6E7 encoding HPV16 E6/E7 (16E6E7) [38] and recombinant
retroviruses [39]. Following the addition of recombinant viral fluid
to cells seeded in 24-well dishes in the presence of 4 mg/ml
polybrene, the cells were infected by the viruses. Stably transduced
cells with an expanded life span were designated transduced
Figure 4. Transmission electron microscopy of cell line intercellular junctions. The junctional complex was detected at the intercellular
junction in THCEC (Cyclin) and HCEC. No component of the intercellular junction was found in THCEC (E6/E7), in which cells grew in multilayers
without being inhibited by cellular contact (scale bar=200 nm).
doi:10.1371/journal.pone.0029677.g004
Figure 5. The pump function of cell lines. Short-circuit currents representing Na
+/K+-ATPase activity from corneal cell monolayers on the insert
well area of 4.67 cm
2 were calculated before and after addition of the Na
+/K+-ATPase inhibitor ouabain. (A) Representative tracings of short-circuit
current (mA/well) obtained with cell monolayers of THCEC (Cyclin) (upper panel), HCEC (middle panel) and THCEC (E6/E7) (lower panel). THCEC
(Cyclin) possessed equal transport activity to HCEC, whereas no pump function was detected in THCEC (E6/E7). (B) Time-course changes in the
average short circuit current of cultured monolayers of cell lines at 1, 5, 10 and 20 min. Data shown are for (m) THCEC (Cyclin) at PD8, (¤) THCEC
(Cyclin) at PD 21, (N) HCEC and (&) THCEC (E6/E7); all data are expressed as mean6SD of four replicate experiments of each cell line.
doi:10.1371/journal.pone.0029677.g005
Corneal Endothelial Cell Line with Pump Function
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transduced human corneal endothelial cell by Cdk4R24C/
cyclinD1 (THCEH (Cyclin)).
Culture of transfected cell lines and growth curve
When the cultures reached subconfluence, the cells were
harvested with 0.25% trypsin and 1 mM EDTA, collected into
tubes, and centrifuged. The cells were counted using a cell viability
analyzer (Vi-CELL Cell Viability Analyzer, Beckman Coulter,
Brea, CA), and population doubling (PD) was calculated. The
pellets were suspended in growth medium, and the cells were
passaged at a density of 5610
5 cells/well in a 100-mm dish. The
original cells were regarded as PD 2 (day 0).
Western blot analysis
Western blotting was conducted as described previously [40].
Antibodies against Cdk4 (ser473; Cell Signaling Technology,
Danvers, MA), CyclinD1 (clone G124-326; BD Biosciences,
Franklin Lakes, NJ), b-actin (sc-1616; Santa Cruz Biotechnology,
Santa Cruz, CA) were used as probes, and horseradish peroxidase-
conjugated anti-mouse, anti-rabbit (Jackson Immunoresearch
Laboratories, West Grove, PA) or anti-goat (sc-2033; Santa Cruz
Biotechnology, Santa Cruz, CA) immunoglobulins were employed
as secondary antibodies.
Immunocytochemistry
Cell lines were grown on Type IV collagen-coated glass dishes
14 days after reaching confluency and were fixed with 4%
formaldehyde (pH 7.0) for 15 min at room temperature. Cell lines
were then rehydrated in phosphate buffered saline (PBS),
incubated with 0.2% Triton X-100 for 15 min and rinsed three
times with PBS for 5 min each. After incubation with 2% BSA to
block nonspecific staining for 30 min, cell lines were incubated
with anti-ZO-1 (1:50; sc-8146; Santa Cruz Biotechnology, Santa
Cruz, CA), anti-N-cadherin (1:50; sc-7939; Santa Cruz Biotech-
nology) and anti-Ki67 (1:100; ab15580; Abcam, Cambridge, UK)
for 16 h at 4uC. After three washes with PBS, cell lines were
incubated with the secondary antibody for 60 min, followed by
counterstaining with 49,6-diamidino-2-phenylindole (1:200; sc-
3598; Santa Cruz Biotechnology) for 10 min.
Semi-quantitative RT-PCR
Total RNA was extracted from 1610
6 cultured HCEC using
the RNeasy Plus mini-kitH (Qiagen, Germantown/Gaithersburg,
MA) according to the manufacturer’s instructions and quantified
by absorption at 260 nm. Total RNA was then reverse-transcribed
into cDNA using Superscript III Reverse Transcriptase (Invitro-
gen, Carlsbad, CA) with oligo random hexamers. cDNAs of each
component were amplified by PCR using specific primers and
DNA polymerase. The reaction was first incubated at 95uC for
10 min, followed by 39 cycles at 98uC for 30 s, 58uC for 30 s and
74uC for 30 s. PCR primers are listed in Table 2.
Quantitative real-time RT-PCR
Total RNA extraction and reverse transcription into cDNA was
carried out as above. Each quantitative real-time RT-PCR for
target genes, including Cell Division Cycle 2 (CDC2) and
proliferating cell nuclear antigen (PCNA), was performed using
the Chromo4 real time detection system (Bio-Rad, Hercules, CA).
For a 20 ml PCR, the cDNA template was mixed with the primers
to final concentrations of 200 nM and 10 ml of SsoFast EvaGreen
Supermix (BIO-RAD), respectively. The reaction was first
incubated at 95uC for 10 min, followed by 45 cycles at 95uC for
10 s, 57uC for 15 s, and 72uC for 20 s.
Transmission Electron Microscopy
Cell lines cultured on Type IV collagen-coated dishes were fixed
in HEPES buffered 2% glutaraldehyde and subsequently post-
fixed in 2% osmium tetroxide for 3 h on ice. Specimens were then
dehydrated in graded ethanol and embedded in the epoxy resin.
Ultrathin sections were obtained by ultramicrotomy and stained
with uranyl acetate for 10 min and modified Sato’s lead solution
for 5 min then submitted to TEM observation (JEM-2000EX,
JEOL).
Measurement of pump function
The pump function of confluent monolayers of HCEC was
measured using an Ussing chamber as described previously [41].
Cells cultured on Snapwell inserts coated with Type IV collagen
were placed in the Ussing chamber EM-CSYS-2 (Physiologic
Instruments, San Diego, CA) with the endothelial cell surface side
in contact with one chamber and the Snapwell membrane side in
contact with another chamber. The chambers were carefully filled
with Krebs-Ringer bicarbonate (120.7 mM NaCl, 24 mM
NaHCO3, 4.6 mM KCl, 0.5 mM MgCl2, 0.7 mM Na2HPO4,
1.5 mM NaH2PO4 and 10 mM glucose bubbled with a mixture of
5% CO2,7 %O 2 and 88% N2 to pH 7.4). The chambers were
maintained at 37uC using an attached heater.
The short-circuit current was sensed by narrow polyethylene
tubes positioned close to either side of the Snapwell, filled with
3 M KCl and 4% agar gel and connected to silver electrodes.
These electrodes were connected to the computer through the
Ussing system VCC-MC2 (Physiologic Instruments) and an iWorx
118 Research Grade Recorder (iWorx Systems, Dover, NH), and
the short-circuit current was recorded by Labscribe2 Software for
Research (iWorx). After the short-circuit current had reached a
steady state, ouabain (final concentration, 1 mM) was added to the
chamber, and the short-circuit current was re-measured. The
pump function attributable to Na
+/K
+-ATPase activity was
calculated as the difference in short-circuit current measured
before and after the addition of ouabain.
Tumorigenesis assay
Cells were harvested by Trypsin/EDTA treatment, collected
into tubes, and centrifuged, and the pellets were suspended in
Table 1. Tumorigenesis assay of cell lines in BALB/C nude mice.
Inoculated cells Total dose (cell/mouse) Number of mice (% mortality) Number of mice with tumor
THCEC (Cyclin) 1.7610
6 3(0) 0
THCEC (E6/E7) 1.7610
6 3(0) 0
HeLa cells 2.0610
6 3(0) 3
doi:10.1371/journal.pone.0029677.t001
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Biosciences) was added to the cell suspension. Cells (1.7610
6)o f
THCEC (Cyclin) and THCEC (E6/E7) were inoculated subcu-
taneously into dorsal flanks of each of three Balb/c nu/nu mice
(CREA, Japan) for 60 days. A total of 2.0610
6 HeLa cells per
mouse were used as positive controls. The skin of dorsal flanks of
inoculated mice was surgically opened and the tumorigenic status
was examined.
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